EFFECTS OF DIETARY SUPPLEMENTATION WITH AURANTIOCHYTRIUM SP. ON ZEBRAFISH GROWTH AS DETERMINED BY TRANSCRIPTOMICS

Effects of Dietary Supplementation with Aurantiochytrium sp. on Zebrafish Growth as Determined by Transcriptomics

The marine protist Aurantiochytrium produces several bioactive chemicals, including EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid), and other critical fish fatty acids.It has the potential to improve growth and fatty acid profiles in aquatic taxa.This study evaluated zebrafish growth performance in response to diets containing 1% to 6-0 ig

read more

Unveiling the charge distribution of a GaAs-based nanoelectronic device: A large experimental dataset approach

In quantum nanoelectronics, numerical simulations have become a ubiquitous tool.Yet the comparison with experiments is often done at a qualitative level or restricted to a single device with a handful of fitting parameters.In this work, we assess the predictive power of these simulations by comparing the results of a single model with a large exper

read more

Outcomes of permanent canines on the cleft side after secondary alveolar grafting using different materials in complete unilateral cleft lip and palate

Abstract The prevalence of impaction of the permanent canine on the cleft side (PCCS) ranges from 12-35% after alveolar bone grafting (ABG).PCCSs usually develop above other permanent teeth in the alveolar process, gradually becoming vertical until they reach the occlusal plane.The type of cleft, hypodontia of lateral incisor on the cleft side, slo

read more

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

Abstract Objective APPEASE is a phase bostik mvp I study to assess the safety, dosing, and efficacy of rivoceranib (a selective, small-molecule inhibitor of VEGFR2) in combination with pembrolizumab.We aimed to treat patients with metastatic malignancies who have progressed through at least first-line therapy, with pembrolizumab 200 mg every 3 week

read more

Experimental study of the effectiveness of the removal of virus hepatitis B, C and parvovirus B19 by the fractionation of blood plasma with ethanol

The purpose of the study was to assess the effectiveness of the removal of nucleic acids (NA), Hepatitis B (HBV) and C (HCV) viruses and parvovirus B19 (B19V) from blood plasma fractions obtained by alcohol separation.The studies were performed in a model experiment by fractionation normal pool plasma donation contaminated with virus-containing sam

read more